Castle Biosciences Surpasses 25,000 Test Reports Delivered for its Barrett’s Esophagus Test
Castle Biosciences’ Barrett’s Esophagus test delivered over 25,000 reports to support risk assessment for Barrett’s Esophagus patients.
Read More
Search Results for: liver disease
Nasal Swab Tests Can Predict COVID Disease Severity
Nasal autoantibodies can predict COVID severity, providing insights for personalized treatment and applications for other respiratory viruses.
Read More
Biotia’s Genomics-Based Urine Test Gains New York State Approval
Biotia’s BIOTIA-ID Urine NGS Assay uses artificial intelligence (AI) and genomics to deliver rapid, highly accurate UTI diagnoses.
Read More
FDA Clears Meningitis/Encephalitis Panel for Rapid, Syndromic Testing
QIAGEN’s Meningitis/Encephalitis Panel received FDA clearance, providing providers with rapid testing for meningitis and encephalitis.
Read More
QIAGEN Gets FDA Clearance for Outpatient Respiratory Treatment Test
QIAGEN’s QIAstat-Dx Respiratory Panel Mini provides fast and accurate diagnosis of upper respiratory infections in outpatient settings.
Read More